WASHINGTON (TIP): Researchers in Texas are reporting that an experimental drug saved monkeys from a virus closely related to Ebola even after symptoms began. The drug targets a strain of Marburg virus that is even more lethal than the Ebola ravaging West Africa. Both viruses take time to multiply in the body before symptoms appear, and few studies have explored how late treatment might be effective. Researchers at the University of Texas Medical Branch at Galveston found that treated monkeys survived even if given the drug three days after infection, when symptoms had begun. Although Wednesday’s study is very small, the work is generating interest because a drug that targets Ebola the same way is under development by a Canadian company, Tekmira Pharmaceuticals Corp.
Related Articles
Indian-Origin Physicist Discovers Material Better Than Graphene
NEW YORK: An Indian-origin scientist has developed a new one atom-thick flat material that could upstage the wonder material graphene for having properties allowing it to be used in advance digital technology. Discovered by Madhu […]
HERE’S A BRA THAT CAN READ MOOD, CURB OVEREATING
LONDON (TIP): British scientists have developed the world’s first smart bra that can detect changes in mood with the hope of preventing emotionally-triggered over-eating in women. The bra has been jointly created by the University […]
Be the first to comment